Horsmans Y - Search Results

1

Immunolocalisation of cytochrome P-450 3A enzymes in human breast carcinoma: relationship with tumour differentiation and steroid receptors.

Galant C, Gala JL, Van Den Berge V, Berlière M, Haumont E, Horsmans Y. Galant C, et al. Among authors: horsmans y. Pharmacol Toxicol. 2001 Mar;88(3):142-6. doi: 10.1034/j.1600-0773.2001.d01-95.x. Pharmacol Toxicol. 2001. PMID: 11245409

2

Immunoquantification of cytochrome P-450 3A on rat paraffin-embedded liver tissue.

Horsmans Y, Stevens M, Geubel A, Harvengt C, Rahier J. Horsmans Y, et al. Liver. 1992 Oct;12(5):344-50. doi: 10.1111/j.1600-0676.1992.tb00584.x. Liver. 1992. PMID: 1447967

3

Absence of CYP3A genetic polymorphism assessed by urinary excretion of 6 beta-hydroxycortisol in 102 healthy subjects on rifampicin.

Horsmans Y, Desager JP, Harvengt C. Horsmans Y, et al. Pharmacol Toxicol. 1992 Oct;71(4):258-61. doi: 10.1111/j.1600-0773.1992.tb00980.x. Pharmacol Toxicol. 1992. PMID: 1454750

4

Biochemical changes and morphological alterations of the liver in guinea-pigs after administration of simvastatin (HMG CoA reductase-inhibitor).

Horsmans Y, Desager JP, Harvengt C. Horsmans Y, et al. Pharmacol Toxicol. 1990 Oct;67(4):336-9. doi: 10.1111/j.1600-0773.1990.tb00840.x. Pharmacol Toxicol. 1990. PMID: 2077527

5

Effects of simvastatin and pravastatin on 6 beta-hydroxycortisol excretion, a potential marker of cytochrome P-450 3A.

Horsmans Y, Desager JP, van den Berge V, Abrassart M, Harvengt C. Horsmans Y, et al. Pharmacol Res. 1993 Oct-Nov;28(3):243-8. doi: 10.1006/phrs.1993.1127. Pharmacol Res. 1993. PMID: 8108314

6

Microsomal function in hepatitis B surface antigen healthy carriers: assessment of cytochrome P450 1A2 activity by the 14C-caffeine breath test.

Horsmans Y, De Koninck X, Geubel AP, Pauwels S. Horsmans Y, et al. Pharmacol Toxicol. 1995 Oct;77(4):247-9. doi: 10.1111/j.1600-0773.1995.tb01021.x. Pharmacol Toxicol. 1995. PMID: 8577634 Clinical Trial.

7

Relationship between mephenytoin, phenytoin and tolbutamide hydroxylations in healthy African subjects.

Horsmans Y, Kanyinda JM, Desager JP. Horsmans Y, et al. Pharmacol Toxicol. 1996 Feb;78(2):86-8. doi: 10.1111/j.1600-0773.1996.tb00185.x. Pharmacol Toxicol. 1996. PMID: 8822040

8

14C-Propoxyphene demethylation in the rat. An example of differences between liver and intestinal drug-presystemic metabolism.

Horsmans Y, Saliez A, van den Berge V, Desager JP, Geubel AP, Pauwels S, Lambotte L. Horsmans Y, et al. Drug Metab Dispos. 1997 Nov;25(11):1257-9. Drug Metab Dispos. 1997. PMID: 9351901

9

Phenytoin hydroxylation in a healthy Caucasian population: bimodal distribution of hydroxyphenytoin urinary excretion.

Horsmans Y, Van den Berge V, Bouckaert A, Desager JP. Horsmans Y, et al. Pharmacol Toxicol. 1997 Dec;81(6):276-9. Pharmacol Toxicol. 1997. PMID: 9444669

10

CYP 3A proteins are expressed in human neutrophils and lymphocytes but are not induced by rifampicin.

Stärkel P, Sempoux C, Van Den Berge V, Stevens M, De Saeger C, Desager JP, Horsmans Y. Stärkel P, et al. Among authors: horsmans y. Life Sci. 1999;64(8):643-53. doi: 10.1016/s0024-3205(98)00606-7. Life Sci. 1999. PMID: 10069527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

335 results

Search Page

Filters